106 related articles for article (PubMed ID: 21782794)
1. Spleen tyrosine kinase suppresses osteoblastic differentiation through MAPK and PKCα.
Yoshida K; Higuchi C; Nakura A; Yoshikawa H
Biochem Biophys Res Commun; 2011 Aug; 411(4):774-9. PubMed ID: 21782794
[TBL] [Abstract][Full Text] [Related]
2. Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.
Kaneshiro S; Ebina K; Shi K; Yoshida K; Otsuki D; Yoshikawa H; Higuchi C
J Bone Miner Metab; 2015 Sep; 33(5):486-95. PubMed ID: 25230818
[TBL] [Abstract][Full Text] [Related]
3. PKCα suppresses osteoblastic differentiation.
Nakura A; Higuchi C; Yoshida K; Yoshikawa H
Bone; 2011 Mar; 48(3):476-84. PubMed ID: 20951242
[TBL] [Abstract][Full Text] [Related]
4. Spleen tyrosine kinase influences the early stages of multilineage differentiation of bone marrow stromal cell lines by regulating phospholipase C gamma activities.
Kusuyama J; Kamisono A; ChangHwan S; Amir MS; Bandow K; Eiraku N; Ohnishi T; Matsuguchi T
J Cell Physiol; 2018 Mar; 233(3):2549-2559. PubMed ID: 28786489
[TBL] [Abstract][Full Text] [Related]
5. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
6. MEK5 suppresses osteoblastic differentiation.
Kaneshiro S; Otsuki D; Yoshida K; Yoshikawa H; Higuchi C
Biochem Biophys Res Commun; 2015 Jul; 463(3):241-7. PubMed ID: 25998381
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104.
Huang YF; Lin JJ; Lin CH; Su Y; Hung SC
J Bone Miner Res; 2012 May; 27(5):1093-105. PubMed ID: 22247071
[TBL] [Abstract][Full Text] [Related]
9. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
[TBL] [Abstract][Full Text] [Related]
10. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
12. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.
Xu JW; Morita I; Ikeda K; Miki T; Yamori Y
Mol Endocrinol; 2007 Feb; 21(2):564-73. PubMed ID: 17095576
[TBL] [Abstract][Full Text] [Related]
14. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
15. Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
Miller AL; Zhang C; Shokat KM; Lowell CA
J Immunol; 2009 Jan; 182(2):988-98. PubMed ID: 19124742
[TBL] [Abstract][Full Text] [Related]
16. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
17. Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation.
Wu NL; Huang DY; Wang LF; Kannagi R; Fan YC; Lin WW
J Invest Dermatol; 2016 Jan; 136(1):192-201. PubMed ID: 26763439
[TBL] [Abstract][Full Text] [Related]
18. M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation.
Watanabe-Takano H; Takano K; Keduka E; Endo T
Exp Cell Res; 2010 Feb; 316(3):477-90. PubMed ID: 19800879
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.
Nakahara T; Sato H; Shimizu T; Tanaka T; Matsui H; Kawai-Kowase K; Sato M; Iso T; Arai M; Kurabayashi M
Biochem Biophys Res Commun; 2010 Apr; 394(2):243-8. PubMed ID: 19903460
[TBL] [Abstract][Full Text] [Related]
20. Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells.
Yang WS; Chang JW; Han NJ; Lee SK; Park SK
Exp Cell Res; 2012 Sep; 318(15):1867-76. PubMed ID: 22659134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
